Opioids disrupt nervous system development by inhibiting the prolifera
tion of neuronal and glial progenitors. These studies explored the hyp
othesis that mu opioid receptors are expressed by immature oligodendro
cytes (OLs) and are functionally related to growth. Antibodies identif
ying the cloned mu opioid receptor demonstrated that cultured OLs expr
essed mu opioid receptor immunoreactivity very early during developmen
t. Cultures were treated with the selective mu opioid receptor agonist
H-Tyr-Pro-Phe (N-Me)-D-Pro-NH2 (PL017; 1 mu M), or PL017 (1 mu M) plu
s the antagonist naloxone (3 mu M). Opioid-dependent changes in DNA sy
nthesis were assessed by determining the proportion of bromodeoxyuridi
ne (BrdU)-labeled O4-immunoreactive OLs. Treatment with PL017 caused a
311% increase in the proportion of O4-immunoreactive OLs incorporatin
g BrdU compared to untreated controls, and these effects were prevente
d by co-administering naloxone. These preliminary results indicate tha
t (i) immature OLs express mu opioid receptors and that (ii) the activ
ation of this receptor type is functionally coupled to DNA synthesis a
nd the cell division cycle. The expression of opioid receptors by OLs
suggests that the endogenous opioid system is widely distributed among
glial types.